The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFeedback Regulatory News (FDBK)

Share Price Information for Feedback (FDBK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 82.50
Bid: 80.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 5.00 (6.25%)
Open: 82.50
High: 82.50
Low: 82.50
Prev. Close: 82.50
FDBK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update re Bleepa®

17 Oct 2019 07:00

RNS Number : 1508Q
Feedback PLC
17 October 2019
 

Feedback plc

 

Update re Bleepa® 

 

Cambridge, 17 October 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, is pleased to provide an update on Bleepa®.

 

The Company is considering a number of potential opportunities for Bleepa® following its launch at the NHS Expo in September 2019. The Company is in advanced discussions with NHS pilot sites whilst additionally pursuing a number of commercial opportunities within and outside the NHS, and hopes to commence Bleepa® pilot schemes in the near future.

 

To date, the Bleepa® product has been well received by the healthcare community and the Company believes that it will enable a number of healthcare providers to provide faster, safer, more efficient care. The Company looks forward to providing further updates in due course.

 

Tom Oakley, CEO of Feedback plc, said:

 

"We are very encouraged by the response to Bleepa® having discussed this with senior NHS executives and clinicians at NHS Expo. The feedback that we have received is that Bleepa® clearly has applications across the healthcare sector, not only in individual hospital settings but also in community and cross site clinical settings. We look forward to making further announcements in relation to Bleepa®, in due course."

 

The Company continues to progress with its strategic review of TexRAD®, a longstanding part of the Feedback portfolio. The Company hopes to complete the strategic review by the end of the calendar year.

 

-Ends-

Enquiries:

 

Feedback plc

Tom Oakley, CEO

Lindsay Melvin, CFO

+44 (0)1954 718072

IR@fbk.com

Allenby Capital Limited (Nominated Adviser)

David Worlidge / Asha Chotai

+44 (0)20 3328 5656

Peterhouse Capital Limited (Joint Broker)

Lucy Williams / Duncan Vasey

 

+44 (0)20 7469 0936

Stanford Capital Partners Limited (Joint Broker)

Patrick Claridge / John Howes

+44 20 3815 8880

 

Instinctif Partners

Rozi Morris / Phillip Marriage

+44 (0)20 7457 2020

feedbackplc@instinctif.com

 

 

Notes to editors

 

About Feedback plc - www.fbk.com

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer.

 

Feedback has launched Bleepa®, a new secure, encrypted medical communication app for clinicians accessible through smartphones, tablets and desktops that facilitates rapid clinical messaging and review of medical grade imaging for all members of a clinical team, directly from a hospital Picture Archiving and Communications System (PACS). For more information on Bleepa®, see www.bleepa.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDMFBLTMBIBBFL
Date   Source Headline
19th Dec 20062:36 pmRNSInterim Results
19th Oct 20063:46 pmRNSHolding(s) in Company
17th Oct 20069:53 amRNSDirector/PDMR Shareholding
28th Sep 20065:25 pmRNSPosting of accounts
27th Sep 20067:01 amRNSFinal Results
18th Apr 20064:55 pmRNSHolding(s) in Company
21st Feb 20061:04 pmRNSHolding(s) in Company
17th Jan 20068:28 amRNSHolding(s) in Company
14th Dec 20057:01 amRNSInterim Results
30th Nov 20052:34 pmRNSHolding(s) in Company
23rd Sep 20052:53 pmRNSConversion of Securities
10th Aug 20057:01 amRNSFinal Results
21st Jul 20055:06 pmRNSHolding(s) in Company
11th Jul 20055:21 pmRNSConversion of Securities
14th Apr 200512:23 pmRNSConversion of Securities
16th Mar 20051:07 pmRNSDisposal
28th Feb 20055:04 pmRNSCirc re. EGM
24th Feb 200512:49 pmRNSStatement re Pension Scheme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.